The DCGI has approved Oxford-AstraZeneca#39;s Covishield and indigenously-developed Covaxin of Bharat Biotech for restricted emergency use in India.from Moneycontrol Technology News https://ift.tt/2Lmq0am
Intraday Tips For Tomorrow, Share Tips For Tomorrow, Nifty Tomorrow Outlook, Share Market Tips Blog
The DCGI has approved Oxford-AstraZeneca#39;s Covishield and indigenously-developed Covaxin of Bharat Biotech for restricted emergency use in India.Stock & Commodity Market Trading Tips © 2011 DheTemplate.com. Supported by Tips for Life and Blogging Tips
Post a Comment